Research Study
View Full Study →
Isoliquiritigenin as a modulator of the Nrf2 signaling pathway: potential therapeutic implications.
Citation
Qiu M., Ma K., Zhang J., Zhao Z., Wang S. et al. (2024). Isoliquiritigenin as a modulator of the Nrf2 signaling pathway: potential therapeutic implications.. Front Pharmacol. DOI: 10.3389/fphar.2024.1395735
Abstract
Abstract not available. See citation for source.
Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.